General BLENREP (Belantamab mafodotin): an effective BCMA-targeting agent for the treatment of heavily...
Clinical trials Axicabtagene ciloleucel as second-line treatment for relapsed/refractory large B-cell lymphoma
Medical Research Next generation sequencing assay for clonality detection in classic Hodgkin lymphoma